Tag Archives: Accelerate Long Island
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More
Biotech was in recovery mode this week. After Biogen’s (NASDAQ: BIIB) disappointing quarterly results send the sector’s indices downward, investors looked to other industry stalwarts, like Gilead Sciences (NASDAQ: GILD), to right the ship (Gilead succeeded, as Alex Lash writes here). On the East Coast, a couple of New York biotechs helped the cause. Those […]
Posted in Boston, Boston blog main, Boston top stories, National blog main, New York blog main, New York top stories | Tagged Accelerate Long Island, Adalimumab, Aegerion Pharmaceuticals, alirocumab, Ariad Pharmaceuticals, Avastin, bevacizumab, Biogen, Biotech, Blueprint Health, Board Vitals, cancer, cCAM Biotherapeutics, Celgene, Constipation, Cormorant Global Healthcare Master Fund, Deerfield Management, Empire State Development, Envisagenics, FDA, Foundation Medicine, Gilead Sciences, Humira, Iclusig, Immuno-oncology, Ironwood Pharmaceuticals, Life Sciences, Long Island Emerging Technologies Fund, Longwood Capital Partners, Marc Beer, Merck, MIH Fund, New York State Innovation Venture Capital Fund, Oncobiologics, OSSB Pharma Fund, PDL BioPharma, plecanatide, ponatinib, Praluent, Proximare Lifesciences Fund, Receptos, Regeneron Pharmaceuticals, Rock Creek Capital, Roundups, Sandford Drexel Smith, Synergy Pharmaceuticals, venBio Select Fund | Comments Off on East Coast Biotech Roundup: Regeneron, Synergy, Foundation & MoreAccelerate LI, Eyeing New Seed Fund, Debuts Ninth Grad: Envisagenics
It’ll be several years before we’ll know whether the efforts of Accelerate Long Island lead to successful, sustainable companies. But with the emergence of its latest graduate today, Envisagenics, Accelerate LI can now say it’s helped get nine startups hailing from Long Island’s research institutions off the ground. Accelerate LI and its strategic partner, the […]
Posted in National blog main, New York, New York blog main, New York top stories | Tagged Accelerate Long Island, Adrian Krainer, Aranata Pharmaceuticals, Cold Spring Harbor Laboratory, Columbia University, deals, Empire State Development, Envisagenics, Goddard Labs, Green Sulfcrete, James Watson, Jove Equity Partners, Launchpad Huntington, Life Sciences, Long Island Emerging Technologies Fund, Maria Luisa Pineda, Martin Akerman, Michael Schatz, Michael Zhang, New York Genome Center, New York State Innovation Venture Capital Fund, PolyNova, Right Dose, RNA, Stacey Sikes, startups, Stony Brook University, Symbiotic Health, SynchroPET, Topspin Fund, Traverse Biosciences, University of Texas, VC, Yaniv Erlich | Comments Off on Accelerate LI, Eyeing New Seed Fund, Debuts Ninth Grad: EnvisagenicsEast Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More
New startups. New data. Financings. Acquisitions. Legal tussles. FDA advisory panels. It’s been that kind of week in East Coast biotech. So grab some coffee and let’s roll through this week’s headlines. —This week a new type of cholesterol-lowering drug was in the spotlight, a class of injectable therapies that block the protein known as […]
Posted in Boston, Boston blog main, Boston top stories, National blog main, New York blog main, New York top stories | Tagged Accelerate Long Island, Acute Myeloid Leukemia, Agios Pharmaceuticals, Alan Crane, alirocumab, Alnylam Pharmaceuticals, Amgen, Amicus Therapeutics, Ankit Mahadevia, Antibiotics, Beta-Thalassemia, Biotech, BlueBird Bio, Celgene, Chuck Wilson, Clarus Ventures, Codagenix, deals, Dicerna Pharmaceuticals, evolocumab, FDA, Gary Glick, Gene Therapy, Immunotherapy, Inflammatory Bowel Disease, IPO, Ironwood Pharmaceuticals, J. Robert Coleman, Life Sciences, Lundbeckfond Ventures, Lycera, Merck, Merck Research Ventures, New Enterprise Associates, PCSK9, Polaris Partners, post-partum depression, Praluent, pyruvate kinase deficiency, Regeneron Pharmaceuticals, Repatha, RNA Interference, Roundups, Sage Therapeutics, Sanofi, Scott Requadt, Seattle Genetics, Sirna Therapeutics, Spero Therapeutics, startups, Stroma, the Kraft Group, Topspin Partners, Unum Therapeutics, Vaccine, Xtuit Pharmaceuticals | Comments Off on East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & MoreWith $2M, Codagenix Becomes Accelerate LI’s First VC-Backed Grad
Accelerate Long Island’s main mission has been to turn the science at its nearby research institutions into full-fledged companies with venture investors of their own. With a small funding round being announced today, Codagenix has become the first one of those projects that can make that claim. Codagenix has raised a $2 million Series A […]
Posted in Boston blog main, National blog main, New York, New York blog main, New York top stories | Tagged Accelerate Long Island, Affinity, Astellas Pharma, Broad Hollow Bioscience Park, Codagenix, Cold Spring Harbor Laboratory, deals, Farmingdale State College, Genocea Biosciences, Goddard Labs, Green Sulfcrete, J. Robert Coleman, Jove Equity Partners, Life Sciences, NIH, OSI Pharmaceuticals, PolyNova, Right Dose, startups, Stony Brook University, SynchroPET, Topspin Fund, Topspin Partners, Traverse Biosciences, Vaccine, VC, virus, Visterra | Comments Off on With $2M, Codagenix Becomes Accelerate LI’s First VC-Backed GradBig Apple Biotech “Bootstraps” Forward at NewYorkBio Meeting
Tom Cirrito was dining out at a Mexican restaurant in midtown Manhattan over a decade ago when he overheard something that piqued his interest. At a table next to him, someone was talking about biotech. Cirrito, then an analyst at Piper Jaffray, was intrigued. He butted in, and his life changed. His restaurant neighbor was […]
Posted in Boston blog main, National blog main, National top stories, New York, New York blog main, New York top stories, San Francisco blog main, San Francisco top stories | Tagged Accelerate Long Island, Accelerator Corp., Allovate, Codagenix, David Schubert, Diagnostics, entrepreneurs, Entrepreneurship Lab NYC, EpiBone, Eric Gertler, Erick Berglund, Gene Therapy, Genomic Expression, Gitte Pedersen, Harlem Biospace, Hina Chaudhry, Icahn School of Medicine at Mount Sinai, Ivan Bergstein, J. Robert Coleman, Kate Rochlin, Life Sciences, Long Island Emerging Technologies Fund, New York City Economic Development Corp., New York Genome Center, NewYorkBio, Novozymes, startups, Stemline Therapeutics, Stony Brook University, Tom Cirrito, vaccines, VentriNova, Weill Cornell Medical College | 1 CommentAccelerate LI’s Latest Startup Aims to Rewire Viruses With Software
Accelerate Long Island seeded its first batch of startups earlier this year, and today it has circled back with its latest investment—a company purporting to use computer tools to whip up synthetic viruses and create new vaccines. Accelerate LI and its strategic funding partner, the Long Island Emerging Technologies Fund, have invested $100,000 total—$50,000 apiece—in […]
Posted in Boston blog main, National blog main, New York, New York blog main, New York top stories | Tagged Accelerate Long Island, Affinivax, Codagenix, dengue virus, E. coli, Eckard Wimmer, Genocea Biosciences, influenza, Jove Equity Partners, Life Sciences, Long Island Emerging Technologies Fund, Long Island High Technology Incubator, National Institutes of Health, respiratory syncytial virus, Robert Coleman, startups, Steffen Mueller, Stony Brook University, Topspin Partners, vaccines, Visterra | Comments Off on Accelerate LI’s Latest Startup Aims to Rewire Viruses With SoftwareEast Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More
Fresh off Memorial Day barbecues, the life sciences world descended on Chicago last week for the American Society of Clinical Oncology’s annual meeting. But it was quickly back to the grind afterward, with deals, IPO news, and much more filling up the headlines on the East Coast. —After a few years fine-tuning its investment strategy, […]
Posted in Boston, Boston blog main, National blog main, New York blog main | Tagged Accelerate Long Island, Akebia Therapeutics, Alexandria Venture Investments, American Society of Clinical Oncology, Anemia, ASCO, AstraZeneca, Biogen Idec, Brad Loncar, Bristol-myers Squibb, cancer, cleantech, Clostridium difficile, Cystic Fibrosis, David Berry, deals, Drugs, Enso Ventures, entinostat, Flagship Ventures, Francois Nader, Goddard Labs, Green Sulfcrete, hemophilia A, hemophilia B, Hepatitis C, Idenix Pharmaceuticals, IPO, Ivacaftor, John Butler, Life Sciences, Long Island Emerging Technologies Fund, Mark Lesko, Mayo Clinic, Merck, Microbiome, NPS Pharmaceuticals, obesity, Pfizer, PolyNova, Radius Health, Roche/Genentech, Roger Pomerantz, Seres Health, SynchroPET, Syndax Pharmaceuticals, Tech, Traverse Biosciences, VC, Vertex Pharmaceuticals, Zafgen | Comments Off on East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & MoreArchives
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- October 2005
- September 2005
- August 2005
- July 2005
- June 2005
- May 2005
- April 2005
- March 2005
- February 2005
- January 2005
- December 2004
- September 2004
- June 2004
- May 2004
- March 2004
- February 2004
- January 2004
- December 2003
- June 2003
- May 2003
- March 9
Meta